This article refers to:
Correction to: Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications
Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R. Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opin Investig Drugs. 2013;22(12):1549-68.
Following publication of this article, an error has been identified in the name of the last author. The author should have included a suffix and be written as Richard De La Garza II.